Utah Medical Products Inc revenue
Utah Medical Products Inc's revenue was $38.5m in fiscal 2025, down 5.8% on the year before. Since fiscal 2009 ($25.9m) it has grown at a compound 2.5% a year. Over the last twelve months it was $36.1m.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26 | 25 | 38 | 42 | 40 | 41 | 40 | 39 | 41 | 42 | 47 | 42 | 49 | 52 | 50 | 41 | 39 | 36 |
| Growth on the year before | — | −3.1% | +50.7% | +9.8% | −2.5% | +1.9% | −2.7% | −2.1% | +5.4% | +1.4% | +11.7% | −10.1% | +16.3% | +6.6% | −3.9% | −18.6% | −5.8% | — |
| Gross profit | 14 | 13 | 22 | 25 | 24 | 25 | 24 | 24 | 26 | 26 | 29 | 26 | 31 | 32 | 30 | 24 | 22 | 21 |
| Gross margin | 53.2% | 52.6% | 59.2% | 60.9% | 59.9% | 60.5% | 60.2% | 60.3% | 63.7% | 62.6% | 62.8% | 60.6% | 63.0% | 61.6% | 59.8% | 59.0% | 57.1% | 57.9% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Utah Medical Products Inc | $36.1m | -7.0% | -11.4% |
| Electrocore, Inc. | $37.0m | 33.5% | 50.4% |
| Cytosorbents Corp | $37.2m | 3.1% | 0.8% |
| Retractable Technologies Inc | $33.9m | -11.2% | -14.7% |
| Orchestra Biomed Holdings, Inc. | $32.0m | 986.1% | 94.5% |
| Precision Optics Corporation, Inc. | $31.5m | 65.2% | 14.4% |
Compare with peers
- Electrocore, Inc. revenue
- Cytosorbents Corp revenue
- Retractable Technologies Inc revenue
- Orchestra Biomed Holdings, Inc. revenue
- Precision Optics Corporation, Inc. revenue
Head to head: ECOR vs UTMDCTSO vs UTMDRVP vs UTMD
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies